RIL
PLRX icon

Rothschild Investment LLC’s Pliant Therapeutics PLRX Stock Holding History

Rothschild Investment LLC’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-80
Closed -$108 – 3147
2025
Q1 		$108 Hold
80
– – ﹤0.01% 2959
2024
Q4 		$1.05K Hold
80
– – ﹤0.01% 2187
2024
Q3 		$897 Buy
80
+40
+100% +$500 ﹤0.01% 2245
2024
Q2 		$430 Buy
40
+30
+300% +$387 ﹤0.01% 2111
2024
Q1 		$149 Buy
+10
New +$165 ﹤0.01% 1915

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Rothschild Investment LLC's PLRX Position: Q2 2025 in Review

Rothschild Investment LLC sold out of Pliant Therapeutics (PLRX) in Q2 2025, closing a stake of 80 shares — an estimated $108 sold.

Rothschild Investment LLC first reported a position in PLRX in Q1 2024 and held it in 5 quarters. The position peaked at $1.05K in Q4 2024. 114 funds tracked by Wall St. Rank hold PLRX as of Q2 2025.

  • Rothschild Investment LLC reported no remaining Pliant Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Rothschild Investment LLC sold 80 Pliant Therapeutics shares in Q2 2025, an estimated $108.
  • Rothschild Investment LLC first reported a position in Pliant Therapeutics in Q1 2024 and held it in 5 quarters.
  • Rothschild Investment LLC's Pliant Therapeutics position peaked at $1.05K in Q4 2024.
  • 114 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2025.

Based on Rothschild Investment LLC's 13F filing for Q2 2025, filed 11 Aug 2025.